These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34672807)

  • 21. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
    Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peculiarities of Humoral Immunity Formation in Medical Institution Employees Recovered from or Vaccinated against COVID-19 in Irkutsk.
    Dubrovina VI; Bryukhova DD; Kiseleva NO; Chesnokova MV; Korytov KM; Pyatidesyatnikova AB; Vishnyakov VA; Balakhonov SV
    Bull Exp Biol Med; 2022 May; 173(1):54-58. PubMed ID: 35622255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    Abbasi J
    JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883
    [No Abstract]   [Full Text] [Related]  

  • 24. Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France.
    Zedan HT; Nasrallah GK
    EBioMedicine; 2021 Sep; 71():103580. PubMed ID: 34525435
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.
    Ferrari D; Mangia A; Spanò MS; Zaffarano L; Viganò M; Di Resta C; Locatelli M; Ciceri F; De Vecchi E
    Clin Chem Lab Med; 2021 Nov; 59(12):2019-2026. PubMed ID: 34614550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.
    Mai HK; Trieu NB; Long TH; Thanh HT; Luong ND; Huy LX; Nguyet LA; Man DNH; Anderson DE; Thanh TT; Chau NVV; Thwaites G; Wang LF; Van Tan L; Hung DT
    Emerg Infect Dis; 2021 Feb; 27(2):663-666. PubMed ID: 33496647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.
    Connolly CM; Chiang TP; Boyarsky BJ; Ruddy JA; Teles M; Alejo JL; Massie A; Werbel WA; Shah AA; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
    Ann Rheum Dis; 2022 Feb; 81(2):293-295. PubMed ID: 34556484
    [No Abstract]   [Full Text] [Related]  

  • 29. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    Abbasi J
    JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836
    [No Abstract]   [Full Text] [Related]  

  • 30. Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors.
    Razafimahatratra SL; Ndiaye MDB; Rasoloharimanana LT; Dussart P; Sahondranirina PH; Randriamanantany ZA; Schoenhals M
    Lancet Glob Health; 2021 Oct; 9(10):e1363-e1364. PubMed ID: 34534478
    [No Abstract]   [Full Text] [Related]  

  • 31. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency.
    Squire J; Joshi A
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):383-384. PubMed ID: 34022388
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP).
    Nehme M; Stringhini S; Guessous I; SEROCoV-Pop Study Team
    Swiss Med Wkly; 2020 Nov; 150():w20398. PubMed ID: 33202421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 37. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
    Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.
    Krsak M; Harry BL; Palmer BE; Franco-Paredes C
    Viral Immunol; 2021 Oct; 34(8):504-509. PubMed ID: 34227891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
    Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
    J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.